Adam Lezack insider trades: Beta Bionics (BBNX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Adam reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | BBNX | ↓ Sell | 998 | $11.21 | $11K | Direct | May 26, 2026 (4d) |
| May 21, 2026 | BBNX | ↓ Sell | 1,000 | $9.95 | $10K | Direct | May 26, 2026 (5d) |
| Dec 1, 2025 | BBNX | ↓ Sell | 1,406 | $29.55 | $42K | Direct | Dec 2, 2025 (1d) |
| Oct 31, 2025 | BBNX | ↓ Sell | 1,406 | $26.87 | $38K | Direct | Nov 5, 2025 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BBNX insiders
Open-market trades in the last 12 months
About Adam Lezack's insider trades
Adam Lezack is an insider at Beta Bionics (BBNX). Since Oct 31, 2025, Adam has reported no open-market purchases and 4 sales worth $100K on SEC Form 4. In the last 12 months: 3 sales ($63K).
Their filings also include grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BBNX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.